ECJ Appeals – Regulation (EC) No 726/2004 – Medicinal products for human use – Active substance ‘eszopiclone’ – Marketing authorisation – Procedure – Statement of position by the Commission – Status of ‘new active substance’ – Concept of ‘actionable measure’
ECLI:EU:C:2012:292, [2012] EUECJ C-477/11 – CO, C-477/11
Bailii
European
Updated: 23 January 2022; Ref: scu.569424
